Clinical Trials Logo

Short Bowel Syndrome clinical trials

View clinical trials related to Short Bowel Syndrome.

Filter by:

NCT ID: NCT04916665 Completed - Clinical trials for Short Bowel Syndrome

Bridging Intestinal Failure With Teduglutide - a Case Report

Start date: January 1, 2019
Phase:
Study type: Observational

In this case report the investigators present a novel strategy for using teduglutide as a bridging therapy to intestinal reconstruction.

NCT ID: NCT04883606 Completed - Clinical trials for Short Bowel Syndrome

A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome

T-Rex
Start date: January 26, 2022
Phase:
Study type: Observational

The main aims of the study are to assess the safety profile of teduglutide (Revestive®) as well as how many people with Short Bowl Syndrome experience a reduction of parenteral support when treated with teduglutide (Revestive®). This study is about collecting existing data only; participants will not receive teduglutide (Revestive®) as part of this study. No new information will be collected during this study. Only data already available in the hospital records will be reviewed and collected for this study. Participants do not need to visit their doctor in addition to their normal visits.

NCT ID: NCT04877431 Completed - Clinical trials for Short Bowel Syndrome

A Study of Teduglutide (Revestive®) in Children, Teenagers and Adults With Short Bowel Disease

Start date: November 5, 2020
Phase:
Study type: Observational

The main aims of the study are to assess the safety profile of Teduglutide (Revestive®) in people with Short Bowel Disease as well as how well people respond to the treatment with Teduglutide (Revestive®). This study is about collecting data only; participants receive Teduglutide (Revestive®) by their doctors according to the clinical practice but not as part of this study. Only standard care information available in the participant's medical records will be reviewed and collected for this study. Participants do not need to visit their doctor in addition to their normal visits.

NCT ID: NCT04867538 Completed - Clinical trials for Short Bowel Syndrome

The Cholelithiasis in Adults With Short Bowel Syndrome

Start date: January 1, 2010
Phase:
Study type: Observational

Short-term studies have shown that patients with short bowel syndrome (SBS) often develop cholestasis or cholelithiasis. In this retrospective cohort study, we aimed to define the incidence, risk factors, and clinical consequences of cholelithiasis in adults with SBS over an extended time period.

NCT ID: NCT04857801 Completed - Clinical trials for Short Bowel Syndrome

Teduglutide in Short Bowel Syndrome Patients

Start date: June 1, 2016
Phase:
Study type: Observational

A retrospective analysis was performed using data of patients suffering from non-malignant SBS-IF. They were treated with teduglutide in a multidisciplinary SBS-IF program at a single university medical center between June 2016 and June 2020.

NCT ID: NCT04832087 Completed - Clinical trials for Short Bowel Syndrome

Pediatric Teduglutide Registry

PTR
Start date: May 18, 2021
Phase:
Study type: Observational [Patient Registry]

Pediatric specific post-marketing registry to evaluate the long-term safety and efficacy of teduglutide.

NCT ID: NCT04743960 Completed - Sleep Clinical Trials

Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition

Start date: October 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether advancing the timing of home parenteral nutrition from overnight to daytime regimens leads to improved glucose profiles and sleep quality, and other changes in plasma metabolic signatures.

NCT ID: NCT04627025 Completed - Clinical trials for Short Bowel Syndrome

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

STARS
Start date: January 26, 2021
Phase: Phase 3
Study type: Interventional

The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.

NCT ID: NCT04474743 Completed - Clinical trials for Chronic Pancreatitis

Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional Study

Start date: October 2, 2018
Phase:
Study type: Observational

Malnutrition and muscle wasting are common consequences of life-threatening, chronic diseases of the gastrointestinal tract. Such diseases include liver cirrhosis, chronic pancreatitis and short bowel syndrome. Malnutrition and muscle wasting increase the risk of complications, reduce the life expectancy and impair the quality of life. The development of malnutrition and muscle wasting is different, as is the diagnosis and nutritional treatment. There are also different mechanisms of origin for the underlying diseases. The aim of the study is to compare data related to nutrition and physical condition of patients with liver cirrhosis, chronic pancreatitis and short bowel syndrome. Malnutrition and muscle wasting within the specific diseases will be characterized and possible correlations will be identified. For this, malnourished and non-malnourished patients of the different diseases are compared with controls patients with non-specific complaints of the gastrointestinal tract as well as with healthy study participants. Data on food intake, physical activity, body composition and body measurements as well as muscle strength and muscle function are recorded. Blood values as well as transport and barrier properties of the intestine will also be examined.

NCT ID: NCT04450472 Completed - Clinical trials for Short Bowel Syndrome

Nonthyroidal Illness Syndrome in SBS

Start date: December 31, 2016
Phase:
Study type: Observational

Nonthyroidal illness syndrome (NTIS) is prevalent in critical illness; it is associated with poor outcomes. However, few studies have focused on the relationship between NTIS and short bowel syndrome (SBS). The aim of this study was to investigate the incidence, etiology, and prognosis of NTIS and its correlation in clinical variables in adult patients with SBS.